Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids research
Author:
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Reference36 articles.
1. Surrogate endpoints in clinical trials: Cancer
2. Surrogate endpoints in clinical trials: Cardiovascular diseases
3. Surrogate endpoints in clinical trials: Ophthalmologic disorders
4. Surrogate endpoints in clinical trials: Definition and operational criteria
Cited by 142 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Application of the Joint Frailty Copula Model for Analyzing Time to Relapse and Time to Death of Women with Cervical Cancer;International Journal of Women's Health;2023-08
2. An augmented likelihood approach for the Cox proportional hazards model with interval-censored auxiliary and validated outcome data—with application to the Hispanic Community Health Study/Study of Latinos;Statistical Methods in Medical Research;2023-06-29
3. Using a surrogate with heterogeneous utility to test for a treatment effect;Statistics in Medicine;2022-11-13
4. Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation;Therapeutic Innovation & Regulatory Science;2022-09-03
5. Incorporating Surrogate Information for Adaptive Subgroup Enrichment Design with Sample Size Re-Estimation;Statistics in Biopharmaceutical Research;2022-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3